show episodes
 
Artwork

1
On Yer Bike Cycling Podcast

Sanny Rudravajhala, Katy Madgwick

icon
Unsubscribe
icon
Unsubscribe
Weekly
 
A very different cycling podcast! For newbies, oldies and everyone in between. Focussing on men’s and women’s pro road racing with a British twist. With broadcaster Sanny Rudravajhala, cycling journalist Katy Madgwick and friends. #OnYerBikePod You’ll usually find us talking about riders like Tadej Pogacar, Remco Evenepoel, Jonas Vingegaard, Mathieu van der Poel, Jasper Philipsen, Primoz Roglic, Ben O’Connor, Richard Carapaz, Biniam Girmay, Tom Pidcock, Geraint Thomas, Mads Pedersen, Wout va ...
  continue reading
 
Brilliant inventions, fresh product designs, iconic brand names and artistic creativity are not only the building blocks of successful business - they deliver a better world for us all. But these valuable forms of intellectual property must be protected in order to flourish. We are the Chartered Institute of Patent Attorneys - the UK's largest intellectual property organisation. Our hosts Lee Davies and Gwilym Roberts chat with entrepreneurs, creatives, patent attorneys and the occasional ju ...
  continue reading
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The B ...
  continue reading
 
Loading …
show series
 
Send us a text Lee and Gwilym have landed in San Diego for the INTA 2025 Annual Meeting! Elisabeth Stewart Bradley, INTA President and Vice President of Innovation Law: Trademarks, Copyrights, and Brand Protection at Bristol Myers Squibb, shares her journey from English literature major to IP lawyer, and how the organisation is evolving to support …
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode, Yaniv Sneor, founder of the Mid Atlantic Bio Angels and CEO at Native State Therapeutics, explains how life science angel investors evaluate biotech startups, and offers tips for young drug developers in search of funding. Our conversation covers how to create a successf…
  continue reading
 
It's all happening, all the time! Just when we thought we'd have a chill day or two it's complete chaos. The Ayuso - del Toro battle rages on. There's a nightmare for Lidl-Trek and heartbreak for Ciccone and then redemption for the team as Carlos Verona pulls off a breakaway win, hot of Kasper Asgreen doing the same too. Oh my word, Primoz Roglic a…
  continue reading
 
Isaac del Toro is in pink but for how long will Juan Ayuso be ok with the situation at UAE?! Sanny and Katy return to review a succession of breathless Giro stages plus a more sedentary sprint stage 12 with an Olav Kooij finish. We see Luke Plapp go on the break, chaos and triumph on the gravel for Wout van Aert and a time trial victory through the…
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna Rose Welch, editorial and community director at Advancing RNA. Werner explains why a single engineered tRNA therapy has the potential to treat "hundreds, if not …
  continue reading
 
Send us a text From helping Scotch Whisky manufacturers by protecting the name in Brazil to working on the IP aspects of the UK's Government's reset in relations with the European Union, the work of our IP Attachés is varied and complex. Lee is joined by his deputy Neil for this deep dive into the important world of global IP diplomacy and trade. A…
  continue reading
 
Sanny and Katy reconvene to talk for a moment on stage 5, reflect on the awful scenes of stage 6 and the crash that neutralised the race and took out a host of riders. They then preview stage 7 before then watching it and coming back together and see whether their predictions pan out. There's Paul Double in the virtual pink, Max Poole flying the Br…
  continue reading
 
We kick off with La Vuelta Feminina as Katy talks us through the action where Demi Vollering reigns in Spain for 2025. Marlen Reusser takes second place across the seven days, and still on her comeback, Anna van der Breggen rounds off the podium. Then we're off to the Giro - Josh Tarling takes the Stage 2 Time Trial as Primoz Roglic wears pink from…
  continue reading
 
Send us a text It's Mental Health Awareness Week and Lee and Gwilym are joined by Penelope Aspinall from the Jonathan’s Voice charity, along with Joanne Donaldson (HLK), Cathy Bailey (UK Intellectual Property Office) and Sally Bannan (Cytiva), for a powerful discussion on the vital mental health training that the charity provides for line managers …
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Bio, talks about the company's post-COVID pivot into infectious diseases (Hepatitis Delta and Hepatitis B) and oncology (solid tumors), how he reprioritized the company's development candida…
  continue reading
 
Mads Pedersen pips Wout van Aert (where have we seen this before?!) to take the Maglia Rosa on Stage One of the Giro d'Italia. A perfect rac for Lidl Trek, not so for Mikel Landa - heartbreak as a crash with 5km to go means he pulls out. Sanny and Katy return to go through the start of the 2025 Giro ending in Albania's capital city, in a quickfire …
  continue reading
 
It's a Tadej Pogacar-free zone! Well, at least it will be when we talk Giro d'Italia. With last year's winner not returning, could there be a new rider lifting Trofeo Senza Fine and wearing La Maglia Rosa by the time we get to Rome in three weeks? Primoz Roglic get back in pink or Juan Ayuso young-gunning for a first Grand Tour win. Katy and Sanny …
  continue reading
 
We love to hear from our listeners. Send us a message. On today's episode, Tolga Tanguler, EVP and Chief Commercial Officer at Alnylam Pharmaceuticals, talks about commercializing RNAi therapies, how they fit into health insurance reimbursement systems, the company's use of value-based contracts, and building therapeutic franchise "skyscrapers." Ta…
  continue reading
 
We love to hear from our listeners. Send us a message. On today's episode I'm speaking with Brian Lortie, President and CEO of Uniquity Bio, about his "no jerk" policy and how his experience building teams at GSK, Endo Pharmaceuticals, and Onspira Therapeutics informs his leadership at Uniquity, a clinical-stage immunology startup backed by Blackst…
  continue reading
 
We love to hear from our listeners. Send us a message. Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global innovation powerhouse. Increased deal activity with Chinese biopharmaceutical companies is injecting new risk into traditional development models in the We…
  continue reading
 
We love to hear from our listeners. Send us a message. On today's episode we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provides useful insights on how to lead teams, especially when those teams have deeper subject matter expertise. Other topics discussed include when to make …
  continue reading
 
Was it ever in doubt? Maybe? Tadej Pogačar attacks exactly where you'd think he would be not before the rest of the peloton gave beating him a really good go. Sanny and Katy reconvene post-Ronde van Vlaanderen where there was a redemption, of sorts for Wout Van Aert, with Pedersen and van der Poel making the podium and kudos to Stuyven and Ganna in…
  continue reading
 
We love to hear from our listeners. Send us a message. Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chemical engineering and molecular modeling, and a professional background that began in Big Pharma and shifted to investing over 15 years ago. Our conversation cov…
  continue reading
 
Mathieu van der Poel is in form with wins at San Remo and E3 but Katy is backing Tadej Pogačar for victory in the biggest race in Belgium. After his and Visma Lease a Bike's nightmare at Dwars door Vlaanderen, Sanny and Katy discuss whether we'll ever see Wout van Aert back to his best. The women's race sees the formidable SD Worx Protime being the…
  continue reading
 
Mathieu van der Poel follows up Milan San Remo with a super win on the E3 Classic, There's consolation for Mads Pedersen who gets his Sunday victory at Gent-Wevelgem - more than just a consolation on the Classics Holy Week in Flanders. Lorena Wiebes makes it 100 not out with brilliant spring sprint victories in Belgium after her own San Remo succes…
  continue reading
 
We love to hear from our listeners. Send us a message. After nearly five years as host of the Business of Biotech podcast, Matt Pillar is handing the mic over to the voice of the Business of Biotech 2.0, veteran life sciences journalist Ben Comer. On this epsiode, Ben shares his nearly 20-year journey covering the pharmaceutical space, from Haymark…
  continue reading
 
Sanny and Katy talk through the men's and women's Milan-San Remo races with all you need to know going into them and out of them and Mathieu van der Poel comes out on top in a 'race for the ages'. The women’s race - well first off it’s back - and it’s Lorena Wiebes who again shows her sprinting might, edging out Marianne Vos when it mattered most. …
  continue reading
 
We love to hear from our listeners. Send us a message. In this final installment of our episodes recorded and filmed on-site at the JP Morgan Healthcare Conference, Nima Farzan, CEO of Latigo Biotherapeutics, shares his company's mission to change the pain management paradigm by way of novel, non-opioid medications that target NAV 1.8 sodium channe…
  continue reading
 
Send us a text The vital intersection between academia and real-world intellectual property practice takes center stage as Lee and Gwilym welcome Enrico Bonadio from City St George’s University of London. His unique journey from IP litigation in Milan to academic research and teaching offers powerful insights into how theoretical and practical pers…
  continue reading
 
We love to hear from our listeners. Send us a message. Dr. Kasper Roet's hands-on work at the Dutch Brain Bank informed his leadership at the biotech QurAlis, where three clinical programs targeting specific genetic mechanisms in ALS are now underway. On this episode of the Business of Biotech, Life Science Leader's Ben Comer joins to co-host a con…
  continue reading
 
Send us a text Join Lee and Gwilym for an engaging conversation with Keven Bader, Chief Executive of the Chartered Institute of Trademark Attorneys, who shares his personal journey in the realm of intellectual property. They discuss pressing issues, such as the increase of unusual trademark filings and the critical need for collaboration among prof…
  continue reading
 
What a brilliant couple of races into Siena! A battle only seen in Rocky films as Demi Vollering beats her mentor and old coach in Anna van der Breggen. In the men's race Tadej Pogacar gets a shoulder tap from history as he crashes in the rainbow bands but STILL wins in tuscany. We DO get the battle between Pogacar and Pidcock that Katy poo-pooed..…
  continue reading
 
We love to hear from our listeners. Send us a message. The latest in our series of Business of Biotech podcasts recorded in-person at JPM in San Francisco features an inspiring conversation with Affinia Therapeutics CEO Rick Modi. Modi shares on how his upbringing in Kenya shaped his adversity-embracing worldview, and how that worldview contributes…
  continue reading
 
Oof! Katy and Sanny return to review the opening Classics weekend. Om Loop had suprises in both the men's and women's pelotons! They dissect the rest of the big news and a look on races taking the wrong lines too AND THEN... it's a big preview - Paris-Nice, Strade Bianche and Tirreno Adriatico - A LOT to go at in a bumper episode! Presenters: Sanny…
  continue reading
 
We love to hear from our listeners. Send us a message. On this episode of the Business of Biotech, recorded on-site at the 2025 JP Morgan Healthcare Conference, we explore a new approach to biotech financing with XOMA Royalty's Owen Hughes and Brad Sitko. The CEO and CIO, respectively, share an innovative royalty aggregation model that mitigates ri…
  continue reading
 
Send us a text Join us for an enlightening episode as we explore the multifaceted theme of Equality, Diversity, and Inclusion (EDI) within the patent profession. Hosted by Lee Davis and Gwilym Roberts, we are thrilled to have guests Greg Iceton and Alexandra Wood share their insights and experiences, shedding light on important EDI concepts and the…
  continue reading
 
We love to hear from our listeners. Send us a message. Recorded in-person at the JP Morgan Healthcare Conference in San Franscisco, this episode finds Matt Pillar and Ben Comer exploring the evolution of gene therapy with Dr. Tom Chalberg, Founder, Chairman, & CEO at Genascence. We discuss ATMPS' transition from treating rare diseases to addressing…
  continue reading
 
Send us a text Our latest podcast episode dives into the intriguing journey of Tom Bridgewater, CIPA Honorary Informals Representative who transformed his physics and robotics expertise into a rewarding career in intellectual property. Tom shares valuable insights about the challenges of transitioning to IP, the importance of supportive training, a…
  continue reading
 
We love to hear from our listeners. Send us a message. Ran Zhang was hire number one at Landmark Bio back in 2021. Today, she's CEO of the 70+ employee cell and gene therapy manufacturer. We caught up with her and Life Science Leader chief editor Ben Comer at the JP Morgan Healthcare Conference in San Francisco for a discussion on Landmark's role i…
  continue reading
 
Send us a text Join Lee and Gwilym for an enlightening conversation with Ray Naughton from NEG8 Carbon, a pioneering force in the world of carbon capture technology. Ray takes us on a journey from a humble research project at Trinity College Dublin to a cutting-edge enterprise nominated for the 2025 Earthshot Prize. Ray and the peas discuss how inn…
  continue reading
 
Loads and loads for Sanny and Katy to catch up on, in the women's and men's peloton. There's the Tadej Pogacar Paris-Roubaix rumours and confirmation from Tom Pidcock that, that ain't happening. Pidock wins his first race for Q36.5, whilst Adam Yates takes the Tour of Oman what exactly is Arabic for Peloton and, a better question , is everybody get…
  continue reading
 
We love to hear from our listeners. Send us a message. From the JP Morgan Healthcare Conference in San Francisco, Peter Anastasiou, CEO of Capsida Biotherapeutics, discusses his journey from big pharma to biotech and the challenges he's faces on the leading edge of first-gneration gene therapies. Anastasiou discusses the in-house manufacturing qual…
  continue reading
 
We love to hear from our listeners. Send us a message. From the JP Morgan Healthcare Conference in San Francisco, Dr. Stefan Scherer shares insight from 3T Bioscience's transition from clinical medicine to drug development, and his experiences in biotech leadership along the way. Dr. Scherer discusses the balance between promising advances in T-cel…
  continue reading
 
We love to hear from our listeners. Send us a message. Life Science Leader's Ben Comer and Acumen Pharmaceuticals' Dr. Jim Doherty join the Business of Biotech to discuss Dr. Doherty's lifelong, singular focus on researching therapeis for CNS diseases. We cover the historical challenges associated with the development of new therapeutics for Alzhei…
  continue reading
 
Noemi Ruegg takes the title, thanks to a brilliant attack up Willunga Hill for stage 2. What else did we learn from the first World Tour race of the year for the women's peloton? Well, for one, Chloe Dygert is ready to go. Just like Ruegg, Daniek Hengeveld announces herself on the world stage, Sanny and Katy take you through all three stages of the…
  continue reading
 
We love to hear from our listeners. Send us a message. Andrey Doronichev, known to many simply as Dobry, is perhaps best known for taking YouTube mobile. You heard that right. If it weren't for him and the teams he led, YouTube might still be a desktop experience. He went on to lead product strategy at Google before launching the startup Optic in 2…
  continue reading
 
Happy 2025! Sanny and Katy are back together and looking to Australia as road racing returns! They review the Aussie national champs before looking ahead to both the women's and men's Tour down Under. We've got the latest from Visma's press day and on how teams' calendars are shaping up for 2025. There's a blow for Remco Evenepoel and Tom Pidcock's…
  continue reading
 
We love to hear from our listeners. Send us a message. In close partnership woth Johns Hopkins and TriLink BioTechnologies, Jeff Coller, Ph.D. and Michelle Kim, Ph.D. have built a sandbox for RNA developers and aspirational RNA business builders to play in. On this week's episode of the Business of Biotech, we team up once again with Advancing RNA'…
  continue reading
 
Send us a text Join Lee and Gwilym as they welcome Lewis Parle, an IP insurance expert, who shares his fascinating journey into this niche field and helps unravel the complex, yet critical, aspects of insuring intellectual assets. They discuss the challenges of insuring against infringements, and the importance of asserting IP rights. From the chal…
  continue reading
 
We love to hear from our listeners. Send us a message. Dr. Tal Zaks is back, along with Advancing RNA's Anna Rose Welch, for part 2 of "Story Time With Tal." On this week's episode, we turn from his time navigating medical affairs as CMO at Moderna during the COVID 19 pandemic to learn about his latest venture, an mRNA startup called Exsilio Therap…
  continue reading
 
Send us a text Join us as we explore this compelling question with Rachel Free, an esteemed patent attorney and the Vice Chair of the Computer Tech Committee at CIPA. Rachel takes us on a fascinating journey from her initial studies in chemistry to her foray into artificial intelligence, sharing intriguing insights into human-AI collaborations and …
  continue reading
 
We love to hear from our listeners. Send us a message. Zandy Forbes, Ph.D. learned about business risk mitigation in the riskiest of business environments. She was a public markets healthcare investor on Wall Street for well more than a decade. Her hedge fund experience followed the Human Frontiers/Howard Hughes postdoctoral fellowship at the Skirb…
  continue reading
 
We love to hear from our listeners. Send us a message. Tal Zaks, M.D. was Chief Medical Officer at Moderna before, during, and immediately following the company's headline role during the COVID pandemic. If that doesn't pique your interest about the stories he can tell, this episode of the Business of Biotech surely will. Tal is now leading a new m…
  continue reading
 
We love to hear from our listeners. Send us a message. This past spring, Xaira Therapeutics launched with $1 billion in backing, a who's-who mashup of Silicon Valley and biopharma stars led by Marc Tessier-Lavigne in the C-suite, and a mission to develop AI-generated drugs. On this week's episode of the Business of Biotech, we're digging into the c…
  continue reading
 
Loading …

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play